SpartanNash Announces Second Quarter Fiscal 2025 Results
1. SPTN's net sales rose 1.8% to $2.27 billion in Q2 2025. 2. C&S transaction set for late 2025, valued at $26.90 per share. 3. Q2 earnings decreased to $6.2 million, largely due to merger costs. 4. Adjusted EBITDA for the quarter improved to $68.7 million. 5. Lower wholesale sales largely offset increased retail contributions.